110 related articles for article (PubMed ID: 9302751)
1. A candidate Ross River virus vaccine: preclinical evaluation.
Aaskov J; Williams L; Yu S
Vaccine; 1997; 15(12-13):1396-404. PubMed ID: 9302751
[TBL] [Abstract][Full Text] [Related]
2. Development of a candidate vaccine against Ross River virus infection.
Yu S; Aaskov JG
Vaccine; 1994 Sep; 12(12):1118-24. PubMed ID: 7998422
[TBL] [Abstract][Full Text] [Related]
3. The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans.
Kistner O; Barrett N; Brühmann A; Reiter M; Mundt W; Savidis-Dacho H; Schober-Bendixen S; Dorner F; Aaskov J
Vaccine; 2007 Jun; 25(25):4845-52. PubMed ID: 17509734
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial.
Aichinger G; Ehrlich HJ; Aaskov JG; Fritsch S; Thomasser C; Draxler W; Wolzt M; Müller M; Pinl F; Van Damme P; Hens A; Levy J; Portsmouth D; Holzer G; Kistner O; Kreil TR; Barrett PN
Vaccine; 2011 Nov; 29(50):9376-84. PubMed ID: 22001875
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
Holzer GW; Coulibaly S; Aichinger G; Savidis-Dacho H; Mayrhofer J; Brunner S; Schmid K; Kistner O; Aaskov JG; Falkner FG; Ehrlich H; Barrett PN; Kreil TR
Vaccine; 2011 May; 29(24):4132-41. PubMed ID: 21477673
[TBL] [Abstract][Full Text] [Related]
6. An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
Wressnigg N; van der Velden MV; Portsmouth D; Draxler W; O'Rourke M; Richmond P; Hall S; McBride WJ; Redfern A; Aaskov J; Barrett PN; Aichinger G
Clin Vaccine Immunol; 2015 Mar; 22(3):267-73. PubMed ID: 25540268
[TBL] [Abstract][Full Text] [Related]
7. IgG avidity in the diagnosis of acute Ross River virus infection.
Kapeleris J; Lowe P; Phillips D; Wyatt D; Batham M; Devine P
Dis Markers; 1996 Mar; 12(4):279-82. PubMed ID: 8718789
[No Abstract] [Full Text] [Related]
8. A case of encephalitis in central Australia due to Ross River virus?
Lucas RE; Qiao M
Aust N Z J Med; 1999 Apr; 29(2):268-70. PubMed ID: 10342029
[No Abstract] [Full Text] [Related]
9. Detection by ELISA of IgM antibodies to Ross River virus in serum from patients with suspected epidemic polyarthritis.
Oseni RA; Donaldson MD; Dalglish DA; Aaskov JG
Bull World Health Organ; 1983; 61(4):703-8. PubMed ID: 6313247
[TBL] [Abstract][Full Text] [Related]
10. Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice.
Živković I; Bufan B; Petrušić V; Minić R; Arsenović-Ranin N; Petrović R; Leposavić G
Vaccine; 2015 Oct; 33(42):5546-5552. PubMed ID: 26382601
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for Ross River virus infection using blood donors.
Aaskov JG; Chen JY; Hanh NT; Dennington PM
Am J Trop Med Hyg; 1998 Jun; 58(6):726-30. PubMed ID: 9660453
[TBL] [Abstract][Full Text] [Related]
12. Specific IgA antibody response in Ross River virus infection.
Carter IW; Fraser JR; Cloonan MJ
Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():511-3. PubMed ID: 2834291
[TBL] [Abstract][Full Text] [Related]
13. Ross River virus (Togaviridae: Alphavirus) infection (epidemic polyarthritis) in American Samoa.
Tesh RB; McLean RG; Shroyer DA; Calisher CH; Rosen L
Trans R Soc Trop Med Hyg; 1981; 75(3):426-31. PubMed ID: 7324110
[TBL] [Abstract][Full Text] [Related]
14. An epidemic of Ross River virus infection in Fiji, 1979.
Aaskov JG; Mataika JU; Lawrence GW; Rabukawaqa V; Tucker MM; Miles JA; Dalglish DA
Am J Trop Med Hyg; 1981 Sep; 30(5):1053-9. PubMed ID: 7283004
[TBL] [Abstract][Full Text] [Related]
15. Specific and non-specific immunological changes in epidemic polyarthritis patients.
Aaskov JG; Fraser JR; Dalglish DA
Aust J Exp Biol Med Sci; 1981 Oct; 59(Pt 5):599-608. PubMed ID: 7325890
[TBL] [Abstract][Full Text] [Related]
16. Do Ross River and dengue viruses pose a threat to New Zealand?
Maguire T
N Z Med J; 1994 Nov; 107(989):448-50. PubMed ID: 7970354
[TBL] [Abstract][Full Text] [Related]
17. Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.
Taylor A; Melton JV; Herrero LJ; Thaa B; Karo-Astover L; Gage PW; Nelson MA; Sheng KC; Lidbury BA; Ewart GD; McInerney GM; Merits A; Mahalingam S
J Virol; 2016 Apr; 90(8):4150-4159. PubMed ID: 26865723
[TBL] [Abstract][Full Text] [Related]
18. An immunofluorescence assay for human antibodies to Ross River virus.
Aaskov JG; Davies CE
J Immunol Methods; 1979; 25(1):37-41. PubMed ID: 370308
[TBL] [Abstract][Full Text] [Related]
19. [Persistent arthralgias in Ross-River-Virus disease after travel to the South Pacific].
Pröll S; Dobler G; Pfeffer M; Jelinek T; Nothdurft HD; Löscher T
Dtsch Med Wochenschr; 1999 Jun; 124(24):759-62. PubMed ID: 10412359
[TBL] [Abstract][Full Text] [Related]
20. Ross River Virus Seroprevalence, French Polynesia, 2014-2015.
Aubry M; Teissier A; Huart M; Merceron S; Vanhomwegen J; Roche C; Vial AL; Teururai S; Sicard S; Paulous S; Desprès P; Manuguerra JC; Mallet HP; Musso D; Deparis X; Cao-Lormeau VM
Emerg Infect Dis; 2017 Oct; 23(10):1751-1753. PubMed ID: 28930020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
